Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50

Conditions:   COVID-19;   SARS-CoV-2 Interventions:   Drug: Ivermectin;   Drug: Placebo Sponsor:   Insud Pharma Terminated
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials